Перегляд за Автор "Vesnina, l. E."

Зараз показуємо 1 - 1 з 1
  • Ескіз недоступний
    Документ
    Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes
    (2019) Savchenko, L. G.; Digtiar, N. I.; Selіkhova, l. G.; Kaidasheva, E. I.; Shlykova, O. A.; Vesnina, l. E.; Kaidashev, I. P.; Савченко, Людмила Гаврилівна; Дігтяр, Наталія Іванівна; Селіхова, Людмила Григорівна; Кайдашева, Єльвіра Іллівна; Шликова, Оксана Анатоліївна; Весніна, Людмила Едуардівна; Кайдашев, Ігор Петрович
    Liraglutide (L) is the analogue of human glucagon-like peptide 1 which stimulates glucose-dependent insulin secretion and can modify the level of inflammatory biomarkers. L can influence NF-kB inflammatory cascade, but the mechanisms of anti-inflammatory activities of L remain to be determined. In animal models L influenced an activity of Sirtuin l(SIRTl). Moreover, recent evidences strongly suggest that SIRT1 up-regulation may serve as a potent therapeutic approach against development and progression of diabetic complications. The aim of this study was to investigate L effects directed on the pro-inflammatory NF-kB pathway and expression of SIRT1 in obese patients with type 2 diabetes mellitus (DM).